Description
All viatel™bioresorbable polymers can be custom produced for a tailored solution.
Viatel™ ultrapure high-purity bioresorbable polymers offer improved stability and achieve longer, more consistent drug release profiles; they are better suited for sensitive drug compounds in long-acting injectables and implants (LAII).
Viatel™ ultrapure polymers leverage a proprietary purification process that reduces total residual monomer content specifications to below 0.5% with typical batch results of approximately 0.1%. Furthermore, these polymers are pre-filtered during the purification process to ensure exceptional quality.
These low-monomer products are available as GMP grades across the viatel™ platform and provide formulators greater versatility when solving challenging formulation problems.